Delivery Order SPE2DX22D0079-SPE2D825FAEM5
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,294.01 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract utilizes no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $385,020.34 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,541.36 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside contract represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $30,699.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,175.24 by the Defense Logistics Agency's Medical Supply Chain division on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $44,402.40 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's Corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,775.92 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,257.40 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order contract (4568998273) valued at $100,832.86 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under the company's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026....
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D825FAEM5Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $440,289.24 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order exemplifies AmerisourceBergen's established role within the Defense Logistics Agency's pharmaceutical supply chain, supporting the Medical Supply Chain mission to provide medical products to Defense Health Agency beneficiaries, the U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet varied medical procurement requirements across multiple therapeutic domains through open competition. The underlying IDC vehicle enables flexible, efficient procurement of pharmaceutical supplies to support military healthcare programs globally, with the Defense Logistics Agency planning future Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards to diversify the vendor base.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $440.3k | 7/21/25 |